Growth Stocks

Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.

And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.

There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:

  1. Invest mainly in well-established companies;
  2. Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
  3. Downplay or avoid stocks in the broker/media limelight.

Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.

Read More Close
Growth Stocks Library Archives
MAPLE LEAF FOODS INC. $28 is a hold. The company (Toronto symbol MFI; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 124.0 million; Market cap: $3.5 billion; Price-to-sales ratio: 0.7; Dividend yield: 3.4%; TSINetwork Rating: Average; www.mapleleaffoods.com) sells fresh and prepared meats under the Maple Leaf and Schneider labels....
We chose Thomson Reuters as your #1 Conservative Buy for 2025 for several reasons. Those include its high share of the legal and tax information markets and the company’s strong balance sheet. Its long-standing commitment to reward investors with annual dividend increases and share buybacks adds to its appeal.


Note that Thomson Reuters, as a provider of electronic data services, has little risk to tariffs....

You Can See Our WSSF Income-Seeking Portfolio For June 2025 Here.


This month, we are updating our WSSF Portfolio for Income-Seeking Investors.


This portfolio is a good starting point for investors who need income....
QUAKER CHEMICAL CORP. $110 (www.quakerhoughton.com) remains a buy. The company makes specialty chemicals and lubricants for industrial uses. Quaker recently acquired two firms that make surface treatment chemicals for manufacturers: Japan’s Dipsol Chemicals Co., Ltd., purchased for $187.0 million, and U.K.-based Natech Ltd., for $6.5 million....
Since its spinoff from RTX in 2020, elevator maker Otis has seen its shares jump more than 115%. While tariffs are adding to RTX’s costs and hurting new orders, rising demand for maintenance and other services (which now supply over 60% of its revenue) should continue to push the stock higher.


OTIS WORLDWIDE CORP....
IDEXX LABORATORIES INC. $514 is a hold. The company (Nasdaq symbol IDXX; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 80.4 million; Market cap: $41.3 billion; Price-to-sales ratio: 10.9; No dividends paid; TSINetwork Rating: Average; www.idexx.com) makes equipment that veterinarians use to detect disease in animals.


In the first quarter of 2025, Idexx’s sales rose 3.6%, to $998.4 million from $964.1 million a year earlier....
BECTON DICKINSON & CO. $173 is a buy. The medical device maker (New York symbol BDX; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 286.6 million; Market cap: $49.6 billion; Price-to-sales ratio: 2.4; Dividend yield: 2.4%; TSINetwork Rating: Above Average; www.bd.com) acquired the Critical Care product group of Edwards Lifesciences Corp....
PROCTER & GAMBLE CO. $167 is a buy. The consumer products giant (New York symbol PG; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 2.4 billion; Market cap: $400.8 billion; Price-to-sales ratio: 4.9; Dividend yield: 2.5%; TSINetwork Rating: Above Average; www.pg.com) now expects tariffs will cut its sales growth for the fiscal year ending June 30, 2025, to 2% from its earlier forecast for a 3% to 5% increase....
EMBECTA CORP. $11 is still a buy for long-term gains. The company (Nasdaq symbol EMBC; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 58.4 million; Market cap: $642.4 million; Price-to-sales ratio: 0.6; Dividend yield: 5.5%; TSINetwork Rating: Average; www.embecta.com) makes insulin syringes, insulin pens and related products for the treatment of diabetes.


Embecta is also expanding beyond diabetes products....
Since their spinoff from the old General Electric (now operating as GE Aerospace), GE Vernova has soared 245%, while GE HealthCare is up 27%. We like the prospects for both, but prefer GE HealthCare for your new buying.


GE VERNOVA INC. $485 is a hold. The company (New York symbol GEV; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 272.9 million; Market cap: $132.4 billion; Price-to-sales ratio: 3.7; Dividend yield: 0.2%; TSINetwork Rating: Average; www.gevernova.com) makes turbines and related equipment for gas-fired and nuclear power plants, plus equipment for wind farms....